1. Home
  2. VRAX vs MEGL Comparison

VRAX vs MEGL Comparison

Compare VRAX & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • MEGL
  • Stock Information
  • Founded
  • VRAX 2013
  • MEGL 2016
  • Country
  • VRAX United Kingdom
  • MEGL Hong Kong
  • Employees
  • VRAX N/A
  • MEGL N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MEGL Finance: Consumer Services
  • Sector
  • VRAX Health Care
  • MEGL Finance
  • Exchange
  • VRAX Nasdaq
  • MEGL Nasdaq
  • Market Cap
  • VRAX 7.3M
  • MEGL 9.0M
  • IPO Year
  • VRAX 2022
  • MEGL 2022
  • Fundamental
  • Price
  • VRAX $1.66
  • MEGL $0.52
  • Analyst Decision
  • VRAX
  • MEGL
  • Analyst Count
  • VRAX 0
  • MEGL 0
  • Target Price
  • VRAX N/A
  • MEGL N/A
  • AVG Volume (30 Days)
  • VRAX 256.7K
  • MEGL 248.0K
  • Earning Date
  • VRAX 02-05-2025
  • MEGL 10-30-2024
  • Dividend Yield
  • VRAX N/A
  • MEGL N/A
  • EPS Growth
  • VRAX N/A
  • MEGL N/A
  • EPS
  • VRAX N/A
  • MEGL N/A
  • Revenue
  • VRAX $84,872.00
  • MEGL $1,976,138.00
  • Revenue This Year
  • VRAX $5,169.18
  • MEGL N/A
  • Revenue Next Year
  • VRAX $66.97
  • MEGL N/A
  • P/E Ratio
  • VRAX N/A
  • MEGL N/A
  • Revenue Growth
  • VRAX 7.03
  • MEGL 67.75
  • 52 Week Low
  • VRAX $0.60
  • MEGL $0.41
  • 52 Week High
  • VRAX $9.00
  • MEGL $1.38
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 42.25
  • MEGL 42.45
  • Support Level
  • VRAX $1.56
  • MEGL $0.49
  • Resistance Level
  • VRAX $1.86
  • MEGL $0.54
  • Average True Range (ATR)
  • VRAX 0.19
  • MEGL 0.05
  • MACD
  • VRAX -0.04
  • MEGL -0.01
  • Stochastic Oscillator
  • VRAX 26.31
  • MEGL 24.26

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About MEGL Magic Empire Global Limited

Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.

Share on Social Networks: